• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低给药频率对健康结果的影响。

The impact of reducing dose frequency on health outcomes.

作者信息

Richter Anke, Anton Susan F, Koch Peter, Dennett Susan L

机构信息

RTI-Health Solutions, Research Triangle Park, North Carolina 27709, USA.

出版信息

Clin Ther. 2003 Aug;25(8):2307-35; discussion 2306. doi: 10.1016/s0149-2918(03)80222-9.

DOI:10.1016/s0149-2918(03)80222-9
PMID:14512137
Abstract

BACKGROUND

Dosing schedules may be one important factor determining whether patients take their prescribed medication. Schedules may influence whether a patient stays on the prescribed therapy and, if so, the degree to which the regimen is followed. Both factors are important determinants of health outcomes and health care costs.

OBJECTIVE

The goal of this study was to investigate the impact of reducing dose frequency on health outcomes and health care costs.

METHODS

Articles from peer-reviewed journals were identified from the medical literature databases MEDLINE, International Pharmaceutical Abstracts, and HealthSTAR for the years 1985 through 2002. The search included all references that reported on the impact of a change of dose frequency on chronic disease. Search terms used were combinations of dose frequency, dose schedule, and dosing and efficacy, safety, clinical effectiveness, preferences, adherence, compliance, persistence, health-related quality of life, patient satisfaction, resource use, and costs.

RESULTS

Reducing the number of daily doses through extended-release formulations or newer drugs has frequently been shown to provide the patient with better symptom control in a number of disease states. Overall improvements were seen in adherence, patient quality of life, patient satisfaction, and costs. However, results of some studies indicate that not all patients, medications, or diseases may be candidates for reduced dosing due to the potential effects on symptom control, incidence of adverse events, and overcompensation for missed doses.

CONCLUSION

Where feasible, reducing dose frequency may offer benefits for the patient in terms of health outcomes and for the health care budget holder in terms of costs.

摘要

背景

给药方案可能是决定患者是否服用处方药物的一个重要因素。给药方案可能会影响患者是否坚持规定的治疗,如果坚持治疗,还会影响遵循治疗方案的程度。这两个因素都是健康结果和医疗保健成本的重要决定因素。

目的

本研究的目的是调查降低给药频率对健康结果和医疗保健成本的影响。

方法

从1985年至2002年的医学文献数据库MEDLINE、《国际药学文摘》和HealthSTAR中检索同行评审期刊上的文章。检索包括所有报告给药频率变化对慢性病影响的参考文献。使用的检索词包括给药频率、给药方案、给药与疗效、安全性、临床有效性、偏好、依从性、顺应性、持续性、健康相关生活质量、患者满意度、资源利用和成本的组合。

结果

通过缓释制剂或新药减少每日给药次数,在许多疾病状态下经常被证明能为患者提供更好的症状控制。在依从性、患者生活质量、患者满意度和成本方面都有总体改善。然而,一些研究结果表明,由于对症状控制、不良事件发生率和漏服剂量的过度补偿可能产生的潜在影响,并非所有患者、药物或疾病都适合减少给药。

结论

在可行的情况下,降低给药频率可能在健康结果方面为患者带来益处,在成本方面为医疗保健预算管理者带来益处。

相似文献

1
The impact of reducing dose frequency on health outcomes.降低给药频率对健康结果的影响。
Clin Ther. 2003 Aug;25(8):2307-35; discussion 2306. doi: 10.1016/s0149-2918(03)80222-9.
2
The relation between intermittent dosing and adherence: preliminary insights.间歇给药与依从性之间的关系:初步见解。
Clin Ther. 2006 Dec;28(12):1989-95. doi: 10.1016/j.clinthera.2006.12.011.
3
A systematic review of the associations between dose regimens and medication compliance.剂量方案与药物依从性之间关联的系统评价。
Clin Ther. 2001 Aug;23(8):1296-310. doi: 10.1016/s0149-2918(01)80109-0.
4
5
Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.心力衰竭患者每日一次与每日两次服用卡维地洛的依从性:心力衰竭患者中比较每日一次控释卡维地洛CR与每日两次速释卡维地洛IR的依从性和生活质量研究(CASPER)试验
J Card Fail. 2009 Jun;15(5):385-93. doi: 10.1016/j.cardfail.2008.12.010. Epub 2009 Feb 12.
6
7
A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes.固定剂量复方制剂治疗 2 型糖尿病的依从性、治疗满意度和成本的系统评价。
Curr Med Res Opin. 2011 Jun;27(6):1157-68. doi: 10.1185/03007995.2011.570745. Epub 2011 Apr 5.
8
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories.药物依从性:从研究中观察到的处方与实际药物剂量史之间不可靠关系的见解。
Annu Rev Pharmacol Toxicol. 2012;52:275-301. doi: 10.1146/annurev-pharmtox-011711-113247. Epub 2011 Sep 19.
9
Effect of medication dosing frequency on adherence in chronic diseases.药物给药频率对慢性病患者依从性的影响。
Am J Manag Care. 2009 Jun 1;15(6):e22-33.
10
Medicine partnerships.医学合作关系。
Heart. 2003 May;89 Suppl 2(Suppl 2):ii19-21; discussion ii35-7. doi: 10.1136/heart.89.suppl_2.ii19.

引用本文的文献

1
Kinetic Modeling for BT200 to Predict the Level of Plasma-Derived Coagulation Factor VIII in Humans.BT200 动力学建模预测人体血浆源性凝血因子 VIII 水平。
AAPS J. 2024 Jul 12;26(4):81. doi: 10.1208/s12248-024-00952-4.
2
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data.依库珠单抗转换为瑞普昔韦单抗治疗成人抗 hUS 疗效和安全性:真实世界数据。
BMC Nephrol. 2024 Jun 19;25(1):202. doi: 10.1186/s12882-024-03638-3.
3
Two Times Versus Four Times Daily Cephalexin Dosing for the Treatment of Uncomplicated Urinary Tract Infections in Females.
女性单纯性尿路感染治疗中头孢氨苄每日两次与每日四次给药的对比
Open Forum Infect Dis. 2023 Aug 11;10(9):ofad430. doi: 10.1093/ofid/ofad430. eCollection 2023 Sep.
4
Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection.与氟喹诺酮或甲氧苄啶-磺胺甲恶唑口服疗法相比,高剂量口服β-内酰胺类药物对尿路感染继发菌血症的确定性治疗效果。
Antimicrob Steward Healthc Epidemiol. 2023 Sep 8;3(1):e148. doi: 10.1017/ash.2023.435. eCollection 2023.
5
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.REFINE-Lung 采用了一种新颖的多臂随机试验设计,以解决可能的免疫治疗过度治疗问题。
Lancet Oncol. 2023 May;24(5):e219-e227. doi: 10.1016/S1470-2045(23)00095-5.
6
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study.0.6% 比拉斯汀滴眼液的安全性和耐受性:一项为期8周的III期研究
Clin Ophthalmol. 2023 Mar 4;17:735-746. doi: 10.2147/OPTH.S398168. eCollection 2023.
7
PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID.聚乙二醇化重组腺苷脱氨酶在 ADA-SCID 患者中维持解毒和淋巴细胞计数。
J Clin Immunol. 2023 Jul;43(5):951-964. doi: 10.1007/s10875-022-01426-y. Epub 2023 Feb 25.
8
Comparison of Efficacy and Safety of Transdermal Buprenorphine Patch and Conventional Analgesics in Intra-capsular Femur Neck Fracture Post Hemiarthroplasty.透皮丁丙诺啡贴剂与传统镇痛药在半髋关节置换术后股骨颈囊内骨折中的疗效与安全性比较
Indian J Orthop. 2022 Jun 25;56(8):1363-1369. doi: 10.1007/s43465-022-00668-7. eCollection 2022 Aug.
9
Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve.在取卵时经卵巢内注射重组人促卵泡激素进行黄体期卵巢刺激,对即将发生卵巢功能衰竭和卵巢储备功能减退的女性有效。
Biomedicines. 2022 Jun 3;10(6):1312. doi: 10.3390/biomedicines10061312.
10
Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome.比较替格瑞洛与氯吡格雷对急性冠状动脉综合征患者生活质量的影响。
Health Qual Life Outcomes. 2021 Oct 16;19(1):242. doi: 10.1186/s12955-021-01875-w.